Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.
Guan X, Liu R, Wang B, Xiong R, Cui L, Liao Y, Ruan Y, Fang L, Lu X, Yu X, Su D, Ma Y, Dang T, Chen Z, Yao Y, Liu C, Zhang Y.
Guan X, et al. Among authors: dang t.
Clin Transl Med. 2024 Jun;14(6):e1692. doi: 10.1002/ctm2.1692.
Clin Transl Med. 2024.
PMID: 38804602
Free PMC article.